Showing results (41-50 of 400) with videos related to
Sort By:
Pageof 40
Congestive Heart Failure (Greenwich, Conn.)|February 22, 2005
Novel therapies for heart failure: vasopressin and selective aldosterone antagonistsSandeep A Kamath, S Raja Laskar, Clyde W YancyCardiology Research and Practice|November 3, 2012
Left atrial appendage exclusion for stroke prevention in atrial fibrillationTaral K Patel, Clyde W Yancy, Bradley P KnightJournal of the American College of Cardiology|April 15, 2022
Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7Sadiya S Khan, Lauren B Beach, Clyde W YancyCurrent Atherosclerosis Reports|June 22, 2016
Role of Angiotensin Receptor-Neprilysin Inhibition in Heart FailureStuart B Prenner, Sanjiv J Shah, Clyde W YancyThe American Journal of Medicine|November 23, 2006
Beyond diuretics: management of volume overload in acute heart failure syndromesJames A Hill, Clyde W Yancy, William T AbrahamThe American Journal of Cardiology|October 3, 2008
Pharmacologic therapies across the continuum of left ventricular dysfunctionWilliam T Abraham, Barry H Greenberg, Clyde W YancyJACC. Case Reports|April 1, 2020
Heart Failure with Preserved Ejection Fraction and Obesity: Syndrome of cGMP-PKG Deficiency in Post-Menopausal WomenArjun Sinha, Clyde W Yancy, Sanjiv J Shah, et al.JAMA Cardiology|May 7, 2020
Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart FailureNikhil S Bassi, Boback Ziaeian, Clyde W Yancy, et al.Congestive Heart Failure (Greenwich, Conn.)|November 6, 2008
Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failureBrenda Thompson, Mark H Drazner, Daniel L Dries, et al.JAMA Cardiology|July 21, 2016
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart FailureGregg C Fonarow, Adrian F Hernandez, Scott D Solomon, et al.Pageof 40